JHP Pharmaceuticals has entered into an agreement with an undisclosed biotechnology company to provide clinical supplies for late-phase trials. JHP will manufacture the product at its Rochester, MI facility, which provides clinical batch production to commercialization and offers services including regulatory, analytical methods development, package engineering, stability testing and validation.   Stuart Hinchen, JHP’s chief executive officer, said, “Our record of cGMP compliance, driven by expe...